GENERAL ATLANTIC, L.P. Q3 2024 Filing
Filed November 12, 2024
Portfolio Value
$3.5T
Holdings
18
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (18 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALHCALIGNMENT HEALTHCARE | 60,993,323 | $720.9B | 20.50% | |
| 2 | XPXP, INC | 29,617,733 | $531.3B | 15.11% | |
| 3 | DLODLOCAL | 63,906,695 | $511.3B | 14.53% | |
| 4 | 8DTSQUARESPACE | 10,611,073 | $492.7B | 14.01% | |
| 5 | ALKTALKAMI | 15,520,318 | $489.5B | 13.92% | |
| 6 | CNTACENTESSA PHARMACEUTICALS | 9,681,818 | $154.8B | 4.40% | |
| 7 | AKROAKERO THERAPEUTICS | 5,233,989 | $150.2B | 4.27% | |
| 8 | PHVSPHARVARIS | 7,531,252 | $139.5B | 3.97% | |
| 9 | EWCZEUROPEAN WAX CENTER | 13,110,492 | $89.2B | 2.53% | |
| 10 | BLNDBLEND LABS | 19,132,440 | $71.7B | 2.04% | |
| 11 | RPRXROYALTY PHARMA | 1,500,000 | $42.4B | 1.21% | |
| 12 | THRDTHIRD HARMONIC BIO | 2,958,762 | $40.1B | 1.14% | |
| 13 | IMCRIMMUNOCORE | 1,261,684 | $39.3B | 1.12% | |
| 14 | RSKDRISKIFIED | 5,324,998 | $25.2B | 0.72% | |
| 15 | SLRNACELYRIN | 2,889,668 | $14.2B | 0.41% | |
| 16 | 5ZZ0WISH | 609,616 | $3.3B | 0.09% | |
| 17 | GROVGROVE COLLABORATIVE | 936,020 | $1.3B | 0.04% | |
| 18 | ADAGADAGENE | 264,000 | $586.1M | 0.02% |